ClinicalTrials.gov
ClinicalTrials.gov Menu

Impact of Roflumilast on Visceral Adiposity and Metabolic Profile in Chronic Obstructive Pulmonary Disease (RAMBO)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01701934
Recruitment Status : Terminated (The recruitment of the study was prematurely stopped in July 2014 for the following reason; no more study medication.)
First Posted : October 5, 2012
Last Update Posted : November 11, 2014
Sponsor:
Collaborators:
Innovair
Takeda
Information provided by (Responsible Party):
Laval University

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : October 2014
  Estimated Study Completion Date : December 2014
Publications: